Phi news and features
15/06/2022 - Phi Pharma nominates two pre-clinical candidates for formal development towards FIH clinical trial after successful multiple in-vivo Proof of Concept of its technology platform
31/03/2022 - Phi Pharma announces the appointment of Dr Marco Renoldi as new Board Member and Chairman of the company
22/12/2020 - Phi Pharma announces the appointment of Luigi Costa as new Board Member
|
11/12/2020 - Phi Pharma announces the formation of a new Scientific Advisory Board (SAB)
Read Article |
| ||
26/04/2019 - Phi Pharma appoints Dr Franco Merkling as Chief Executive Officer
|
20/12/2016 - Phi Pharma announces closing of CHF 3.7 million (US$3.6 million) series A financing
Read Article |
| ||
|
14/12/2016 - Phi Pharma appoints Dr Tom Shepherd as Chief Executive Officer and Dr Andreas Peer as Head of Chemistry.
Read Article |
| ||
|
12/10/2016 - Phi Pharma collaboration with HES-SO Valais-Wallis in Sion awarded a Swiss CTI Innovation grant to support the generation of proof of concept for a candidate peptide drug conjugate in an oncology indication.
Read article |
| ||